A pilot project was launched in Nagpur, Maharashtra to roll out the World Health Organization (WHO)-recommended triple-drug therapy for lymphatic filariasis to speed up elimination of the disease.
About:
Lymphatic filariasis (LF), commonly known as elephantiasis, is a neglected tropical disease.
Cause:
LF disease is caused mainly by Wuchereria Bancrofti and spread by Culex mosquito. This mosquito grows in dirty accumulated water.
According to the WHO, infection occurs when filarial parasites are transmitted to humans through mosquitoes. The infection is usually acquired in childhood, causing hidden damage to the lymphatic system.
Effect: LF does not kill the affected people, but may cause permanent disfigurement, reduced productivity and social stigma.
Vulnerable groups: The disease affects the poorest population in society, particularly those living in areas with poor water, sanitation and hygiene.
Global scenario: It is one of the oldest and most debilitating neglected disease, which is currently endemic in 73 countries of the world, including India.
Indian scenario: Last year, Union Health Minister released the Accelerated Plan for Elimination of Lymphatic Filariasis (LF) 2018 for India at the 10th meeting of Global Alliance to Eliminate Lymphatic Filariasis (GAELF) held in New Delhi.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
